YVONNE FULLER-FONTENOT: Open Payments
NPI 1861422362 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,202 in 76 payments from 5 companies in 2025. Trend: 2023 $10,550 · 2024 $15,823 · 2025 $24,202
Speaker / faculty: $15,975Travel & lodging: $3,278Food & beverage: $1,908Consulting: $1,900Speaker / faculty: $1,140
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 23 | $13,299 |
| Gilead Sciences, Inc. | 25 | $6,566 |
| Intercept Pharmaceuticals, Inc. | 11 | $4,180 |
| ABBVIE INC. | 16 | $137 |
| Novo Nordisk Inc | 1 | $19 |
Products named: REZDIFFRA, Livdelzi, OCALIVA, Epclusa, RINVOQ, Wegovy, SKYRIZI.
Industry payments across NY — which companies pay providers there.
